Giuseppe Gatti1, Luca Dell’Angela2, Bruno Pinamonti2, Alessandro Moncada1, Alessandro Minati1, Bernardo Benussi1, Gianfranco Sinagra2, Aniello Pappalardo1
Divisions of 1Cardiac Surgery and 2Cardiology, Cardiovascular Department, Ospedali Riuniti e Università di Trieste, Trieste, Italy
Background and aim of the study: For patients who require aortic root replacement but are unwilling or unable to receive anticoagulants, a composite conduit was assembled intraoperatively that contained a stented biological valve sutured inside a vascular tube graft, rather than at its extremity. This simple modification of the Bentall concept may provide several advantages. The results obtained with this conduit over an 11-year period were analyzed.
Methods: Between May 2001 and April 2012, 101 consecutive patients (mean age 68.3 ± 9.2 years) underwent aortic root replacement with the bioprosthetic valved conduit. Aortic pathologies included degenerative disease in 61 patients (60.4%), atherosclerosis in 20 (19.8%), annuloaortic ectasia in 12 (11.9%), porcelain aorta in four (4.0%), and acute dissection in four (4.0%). The whole ascending aorta was replaced in 79 patients (78.2%); a hemiarch reconstruction and a total arch replacement were added in 18 (17.8%) and four (4.0%) patients, respectively. Hypothermic circulatory arrest was
performed in 60 cases (59.4%). Forty patients (39.6%) underwent additional cardiac procedures. All perioperative data were collected prospectively.
Results: There were five (5.0%) hospital deaths. During a mean follow up of 3.8 ± 2.4 years there were two non-valve-related cardiac deaths and five non-cardiac deaths. The seven-year actuarial survival was 79.2% (95% CI 67.0-91.4%). Bioprosthetic structural dysfunction occurred in only one patient; reoperation was easily performed by replacing the valve within the vascular graft. In the remaining 88 patients (87.1%), echocardiographic assessment showed a low transaortic mean pressure gradient (7.2 ± 4.7 mmHg) and left ventricular wall mass reduction (p = 0.0002).
Conclusion: This valved conduit is a safe and durable option for replacing the aortic root, thus facilitating the technique of implantation and simplifying reoperation in the case of valve failure.
The Journal of Heart Valve Disease 2013;22:500-508
|Aortic Root Replacement with a Stented Bioprosthetic Valved Conduit: Mid-Term Results|
Click the above hyperlink to view the article, right click (Ctrl click on a Mac) to open in a new browser window or tab.
Please click the button below to purchase this article. Single article purchases are provided at $50.00 per article. Upon clicking the button below, single article user account subscription details are requested and, upon successful payment, a single article user account is created. Single articles are availble in your account for seven days after purchase.